We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6501:TSEHitachi, Ltd. Analysis

Data as of 2026-06-14 - not real-time

¥4,657.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hitachi trades at ¥4,657, well below its 30‑day DCF fair value of ¥5,573, implying ~27% upside. The stock’s PE of 26.4 is comfortably under the industry average of 30.6, signaling relative cheapness. RSI of 38 and MACD histogram at –56 point to short‑term oversold conditions, while the 20‑day SMA sits above price, suggesting a potential bounce. Support at ¥4,579 and resistance at ¥5,375 frame the next price corridor. Volatility is high at ~41% over 30 days and beta slightly above 1, indicating price swings will be pronounced. The balance sheet shows a high debt‑to‑equity of 14.9, a notable risk factor despite robust cash generation (free cash flow ¥1.15 trillion).
Recent strategic alliances with Google Cloud and Intel to deliver physical AI, edge AI and quantum computing solutions provide a clear growth catalyst. These partnerships align with Hitachi’s digital systems segment, which is expected to drive revenue growth of 11% YoY. The dividend yield of 1.2% with a payout ratio under 30% appears sustainable. Analyst consensus is a “Buy” with a median target of ¥6,100, reinforcing the upside thesis. Overall, the combination of undervaluation, strong cash flow, and new tech collaborations supports a bullish stance. Investors should, however, monitor debt levels and market volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • DCF implied upside of ~27%
  • Oversold technical indicators (RSI 38, bearish MACD)
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic AI and cloud partnerships with Google and Intel
  • Revenue growth of ~11% YoY
  • Undervalued relative to peers (PE 26.4 vs industry 30.6)

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified conglomerate business model
  • Sustainable dividend with low payout ratio
  • Strong free cash flow and long‑term DCF valuation

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin7.58%
P/E Ratio26.4
ROE13.30%
ROA5.29%
Debt/Equity14.90
P/B Ratio3.2
Op. Cash Flow¥1668.1B
Free Cash Flow¥1145.4B
Industry P/E30.6

Technical Analysis

TrendBullish
RSI38.4
Support¥4,579.00
Resistance¥5,375.00
MA 20¥5,008.30
MA 50¥4,959.30
MA 200¥4,798.44
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value¥5,573.38
Target Price¥5,914.29
Upside/Downside27.00%
GradeUndervalued
TypeBlend
Dividend Yield1.20%

Risk Assessment

Beta1.04
Volatility40.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.